Cargando…

First international quality control programme for laboratories measuring antimicrobial drugs to support dose individualization in critically ill patients

OBJECTIVES: International quality control (proficiency testing) programmes are instituted to safeguard the analytical performance of laboratories and to aid these laboratories in identifying sources of error in their analytical methods. We describe the first international quality control programme f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallenburg, E, Brüggemann, R J, Asouit, K, Teulen, M, de Haan, A F J, Franssen, E J F, Aarnoutse, R E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816175/ https://www.ncbi.nlm.nih.gov/pubmed/33094803 http://dx.doi.org/10.1093/jac/dkaa445

Ejemplares similares

Individualization of Piperacillin Dosing for Critically Ill Patients: Dosing Software To Optimize Antimicrobial Therapy
por: Felton, T. W., et al.
Publicado: (2014)

Higher Dosage of Ciprofloxacin Necessary in Critically Ill Patients: A New Dosing Algorithm Based on Renal Function and Pathogen Susceptibility
por: Gieling, Emilie M., et al.
Publicado: (2020)

An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
por: Wallenburg, Eveline, et al.
Publicado: (2022)

Correction to: An Integral Pharmacokinetic Analysis of Piperacillin and Tazobactam in Plasma and Urine in Critically Ill Patients
por: Wallenburg, Eveline, et al.
Publicado: (2022)

Optimizing Antimicrobial Drug Dosing in Critically Ill Patients
por: Póvoa, Pedro, et al.
Publicado: (2021)

High unbound flucloxacillin fraction in critically ill patients
por: Wallenburg, Eveline, et al.
Publicado: (2021)

Population pharmacokinetics of intravenous cefotaxime indicates that higher doses are required for critically ill children
por: Hartman, Stan J. F., et al.
Publicado: (2022)

Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies
por: Jansen, Anouk M. E., et al.
Publicado: (2023)

Effect of high-dose selenium substitution on selected laboratory parameters and prognosis in critically ill patients
por: Brodska, H, et al.
Publicado: (2009)

Fundament and Prerequisites for the Application of an Antifungal TDM Service
por: Brüggemann, Roger J. M., et al.
Publicado: (2015)

Effect of high-dose selenium substitution on selected laboratory parameters and prognosis in critically ill patients
por: Valenta, J, et al.
Publicado: (2007)

Antimicrobial dosing in critically ill patients with sepsis-induced acute kidney injury
por: Mishra, Shakti Bedanta, et al.
Publicado: (2015)

Antimicrobial dosing in critically ill patients with sepsis-induced acute kidney injury
por: Kumar, Anish, et al.
Publicado: (2015)

Cotrimoxazole - optimal dosing in the critically ill
por: Brown, Glen R
Publicado: (2014)

Antimicrobial exposure and the risk of delirium in critically ill patients
por: Grahl, Jessica J., et al.
Publicado: (2018)

Clustering of critically ill patients using an individualized learning approach enables dose optimization of mobilization in the ICU
por: Fuest, Kristina E., et al.
Publicado: (2023)

Acute onset heart failure due to reverse type Takotsubo cardiomyopathy caused by a single dose of 4-Fluoroamphetamine in a healthy young individual
por: van der Pas, R.S.D., et al.
Publicado: (2020)

Cathelicidin antimicrobial protein, vitamin D, and risk of death in critically ill patients
por: Leaf, David E, et al.
Publicado: (2015)

Current Ceftriaxone Dose Recommendations are Adequate for Most Critically Ill Children: Results of a Population Pharmacokinetic Modeling and Simulation Study
por: Hartman, Stan J. F., et al.
Publicado: (2021)

The role of laboratory testing in hospitalised and critically ill COVID-19-positive patients
por: Omar, S, et al.
Publicado: (2020)

Adequate Antimicrobial Dosing in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation: Where to Go from Here?
por: Spriet, Isabel, et al.
Publicado: (2022)

Personalized Piperacillin Dosing for the Critically Ill: A Retrospective Analysis of Clinical Experience with Dosing Software and Therapeutic Drug Monitoring to Optimize Antimicrobial Dosing
por: Chiriac, Ute, et al.
Publicado: (2021)

The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients
por: Garzotto, F., et al.
Publicado: (2016)

Optimization of flucloxacillin dosing regimens in critically ill patients using population pharmacokinetic modelling of total and unbound concentrations
por: Jager, Nynke G L, et al.
Publicado: (2020)

Pharmacokinetics and Target Attainment of Antibiotics in Critically Ill Children: A Systematic Review of Current Literature
por: Hartman, Stan J. F., et al.
Publicado: (2019)

What’s New in Critical Illness and Injury Science? Weighing the evidence for dexmedetomidine dosing in critically ill patients with obesity
por: Hejal, Rana, et al.
Publicado: (2023)

Effect of critical illness on the pharmacokinetics and dose-response relationship of midazolam
por: Ovakim, D, et al.
Publicado: (2012)

Antimicrobial Stewardship Using Biomarkers: Accumulating Evidence for the Critically Ill
por: Kyriazopoulou, Evdoxia, et al.
Publicado: (2022)

Optimizing antimicrobial therapy in critically ill patients
por: Vitrat, Virginie, et al.
Publicado: (2014)

The National Tuberculosis Control Programme of Liberia Laboratory Programme Performance
por: Desta, Kassaye Tekie, et al.
Publicado: (2019)

Pharmacokinetics of long-lasting, high-dose dexmedetomidine infusions in critically ill patients
por: Iirola, T, et al.
Publicado: (2011)

Optimal Dosing of Enoxaparin in Critically Ill Patients with Venous Thromboembolism
por: Abdulla, Aliya, et al.
Publicado: (2023)

Continuation of therapeutic dose heparin for critically ill patients with COVID-19
por: Bradbury, Charlotte A., et al.
Publicado: (2023)

An antimicrobial stewardship program improves antimicrobial treatment by culture site and the quality of antimicrobial prescribing in critically ill patients
por: Katsios, Christina M, et al.
Publicado: (2012)

Tigecycline Dosing Strategies in Critically Ill Liver-Impaired Patients
por: Amann, Lisa F., et al.
Publicado: (2022)

Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis
por: te Brake, Lindsey H. M., et al.
Publicado: (2019)

Immunomodulation in the critically ill
por: Webster, N.R., et al.
Publicado: (2009)

Cost Evaluation of Dried Blood Spot Home Sampling as Compared to Conventional Sampling for Therapeutic Drug Monitoring in Children
por: Martial, Lisa C., et al.
Publicado: (2016)

Critically Ill vs. Non-Critically Ill Patients With COVID-19 Pneumonia: Clinical Features, Laboratory Findings, and Prediction
por: Hong, Wandong, et al.
Publicado: (2021)

Pharmacy intervention on antimicrobial management of critically ill patients
por: Ijo, Immanuel, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_ajc6ljl5ga5qd3lfillvrlfa5j